about
Flotillin microdomains interact with the cortical cytoskeleton to control uropod formation and neutrophil recruitmentMacrophage and Innate Lymphoid Cell Interplay in the Genesis of FibrosisIL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degenerationActivated factor X signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells.MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion.Oncostatin M receptor-beta signaling limits monocytic cell recruitment in acute inflammation.The hydroxylase inhibitor dimethyloxallyl glycine attenuates endotoxic shock via alternative activation of macrophages and IL-10 production by B1 cells.Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.Cutting edge: suppression of GM-CSF expression in murine and human T cells by IL-27Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity.The schistosoma granuloma: friend or foe?The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophagesThe helminth T2 RNase ω1 promotes metabolic homeostasis in an IL-33- and group 2 innate lymphoid cell-dependent mechanism.Regulation of IL-1β-induced NF-κB by hydroxylases links key hypoxic and inflammatory signaling pathways.Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice.IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis.Interleukin-6 signaling drives fibrosis in unresolved inflammation.ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control.IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation.Ligation of TLR7 on CD19(+) CD1d(hi) B cells suppresses allergic lung inflammation via regulatory T cells.PD-L1hi B cells are critical regulators of humoral immunity.Btk regulates macrophage polarization in response to lipopolysaccharide.Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization.Helminth Modulation of Lung Inflammation.Perinatal Activation of the Interleukin-33 Pathway Promotes Type 2 Immunity in the Developing Lung.The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses.Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis.Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1.Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells.Highly efficient CRISPR-targeting of the murine Hipp11 intergenic region supports inducible human transgene expressionCell Survival and Cytokine Release after Inflammasome Activation Is Regulated by the Toll-IL-1R Protein SARMAsymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction
P50
Q24604033-CE09AD2B-2072-401F-A27A-442D15EBA79BQ26774652-1981915B-3F7E-45B4-BE75-287B928AD6C6Q28237337-472046CF-E18E-4514-945B-377096699226Q33558189-A7FB77B8-66DA-46D0-A607-3D1EC5D934B9Q34106637-99CB0E87-2C06-450F-96E8-7C1C5AC71498Q34656753-A3B5590E-CEE5-4828-A7B3-8AAB1F6C536BQ35167567-7BDB3EB8-6760-4298-8193-AFDF47CC06A8Q35358840-81A7BC2F-EF41-46F9-BFBC-E9150BE1B3DBQ36179742-B58A4921-0A61-4AA4-B04E-B9D8709C75CFQ36526371-29E899EB-2BCA-4795-B49A-627CCEB5211EQ36764281-63762CBE-5BAE-4515-8184-34564CAA1B44Q36876563-2B3A0C5C-6B6B-4B3B-A041-DC58DBD52FCCQ37151880-540B3397-7332-48E0-91A5-FDE6189ACE14Q37319845-F2A19E90-CF35-420D-AE9B-ADDD8CBDB12AQ37358129-750519D3-9790-44F5-A346-8F6916630721Q37474764-9E2D8C8F-3A80-44A6-9117-B21E7774CA82Q37572817-9D1342B9-9399-402A-ABFB-5D24BA8309C0Q40118341-0B3B95BE-BB00-413D-BBD0-ED1E78FAAB77Q40172237-F6A68E0A-101F-4854-9C1E-45F6399BCEB6Q41019222-C6316018-0530-4664-80D3-FECE2FB84D4EQ41436003-35F9CD9E-D122-4414-9852-C50F7316F579Q41529474-FA7F5A63-831E-4FB9-9B6F-04B4C7434BB2Q41882583-CCD752F7-7F86-4DF9-8652-2E9E5BC42A2DQ43694518-9F3DE5C6-1F3F-49EA-A932-A060025F9F28Q47552930-B218173F-ACA3-4522-9054-7DF68A3A308AQ49131456-9766779E-E40C-49F2-929C-316D6E978417Q49933333-138C2D49-B635-4A31-BAD6-05FBB3308731Q52413082-E146606C-40FB-4FC3-A296-44C836C7C11FQ52723589-38808656-D56F-4747-BBE6-994389BC147EQ54378086-ABCBF2D4-7E0C-467C-9DB7-846670C79A74Q91770244-C2E9C403-BA6C-4AF5-8F8D-50E3F2B37143Q91928259-7E6AC911-36EE-4E8A-8B6C-326235D86A5AQ93008907-203F5AE5-190E-4D27-A610-CCB492BE7547Q93133573-9480688D-7241-4E51-A4DE-EB03AA9363B0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Emily Hams
@ast
Emily Hams
@en
Emily Hams
@es
Emily Hams
@nl
Emily Hams
@sl
type
label
Emily Hams
@ast
Emily Hams
@en
Emily Hams
@es
Emily Hams
@nl
Emily Hams
@sl
prefLabel
Emily Hams
@ast
Emily Hams
@en
Emily Hams
@es
Emily Hams
@nl
Emily Hams
@sl
P106
P21
P31
P496
0000-0002-9745-3246